被担保人名称：天乾食品有限公司（以下简称"天乾食品"）、武汉天益 畜牧有限公司（以下简称"武汉天益"）、武汉天乾农牧有限公司（以 下简称"武汉天乾"）、武穴市强大牧业有限公司（以下简称"武穴牧 业"）、宜昌天域农牧有限公司（以下简称"宜昌天域"）、宜都天乾 农牧有限公司（以下简称"宜都天乾"）、宜都天乾农牧有限公司麻城 分公司（以下简称"宜都天乾麻城分"），以上统称"天乾食品及其下 属子公司" 是否为上市公司关联人：否 本次担保金额及已实际为其提供的担保余额：本次担保金额合计为不超过 人民币 1,800.00 万元，本次担保前公司对天乾食品、武汉天乾、宜昌天 域、宜都天乾、宜都天乾麻城分的担保余额分别为人民币 1,000.00 万 元、1,368.00 万元、3,243.55 万元、133.70 万元、523.57 万元，对其他下 属子公司的担保余额为 0 万元。 本次担保不存在反担保 公司及控股子公司不存在逾期担保的情形 特别风险提示：本次被担保人天乾食品、宜昌天域、宜都天乾麻城分为资 产负债率超过 70%的控股子公司，敬请投资者注意相关风险。 一、担保情况概述 （一）本次担保履行的内部决策程序 天域生物科 ...

证券代码：603717 证券简称：天域生物 公告编号：2025-044 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 天域生物科技股份有限公司（以下简称"公司"）于 2024 年 08 月 13 日召开 第四届董事会第二十九次会议，审议通过了《关于继续使用部分闲置募集资金暂 时用于补充流动资金的议案》，同意公司在确保不影响募集资金投资项目实施及 募集资金使用的情况下，继续使用不超过人民币 7,400.00 万元的闲置募集资金暂 时补充公司流动资金，使用期限自董事会审议通过之日起不超过十二个月。具体 内容详见公司于 2024 年 08 月 14 日在上海证券交易所官方网站及指定信息披露媒 体上发布的《关于归还募集资金及继续使用部分闲置募集资金暂时补充流动资金 的公告》（公告编码：2024-083）。 根据募集资金投资项目进度及资金需求，公司已于 2025 年 06 月 19 日提前归 还人民币 750.00 万元至募集资金专用账户，并及时将上述募集资金的提前归还情 况告知保荐机构及保荐代表人。 天域生物科技股份有限公司 关于提 ...

关于提前归还部分暂时用于补充流动资金的 闲置募集资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：603717 证券简称：天域生物 公告编号：2025-044 天域生物科技股份有限公司 截至本公告日，公司已累计归还用于暂时补充流动资金的闲置募集资金 1,250.00 万元（含本次），其余用于暂时补充流动资金的 6,150.00 万元募集资金 将在到期日之前归还，届时公司将及时履行信息披露义务。 特此公告。 天域生物科技股份有限公司董事会 2025 年 06 月 20 日 1 天域生物科技股份有限公司（以下简称"公司"）于 2024 年 08 月 13 日召开 第四届董事会第二十九次会议，审议通过了《关于继续使用部分闲置募集资金暂 时用于补充流动资金的议案》，同意公司在确保不影响募集资金投资项目实施及 募集资金使用的情况下，继续使用不超过人民币 7,400.00 万元的闲置募集资金暂 时补充公司流动资金，使用期限自董事会审议通过之日起不超过十二个月。具体 内容详见公司于 2024 年 08 月 14 日在上海 ...

证券代码：603717 证券简称：天域生物 公告编号：2025-043 天域生物科技股份有限公司 1 案件所处的仲裁阶段：已裁决，收到上海仲裁委员会《裁决书》 上市公司所处的当事人地位：仲裁申请人 涉案金额：43,295,330.52 元及本案仲裁费用 是否会对上市公司损益产生负面影响：本次《裁决书》能否顺利执行以 及裁定金额到账时间等存在重大不确定性，本次仲裁案件对公司本期利 润或期后利润的具体影响，将依据《裁决书》的履行和实际执行情况以 及审计机构对财务报表的审计确认情况为准。敬请广大投资者谨慎决策， 注意投资风险。 生因未如期履行业绩补偿义务一案提起仲裁申请。2023 年 08 月 30 日，公司收到 上海仲裁委员会送达的"（2023）沪仲案字第 4766 号争议仲裁案"《仲裁通知 书》，具体内容详见公司于 2023 年 08 月 31 日在上海证券交易所官方网站和指定 信息披露媒体上发布的《关于业绩补偿事项申请仲裁的公告》（公告编码：2023- 093）。 二、本次仲裁裁决情况 近日，公司收到上海仲裁委员会送达的"（2023）沪仲案字第 4766 号争议 仲裁案"《裁决书》，裁决结果如下： 1、被申请 ...

2025 年 5 月养殖业务主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 天域生物科技股份有限公司（以下简称"公司"）现将 2025 年 5 月养殖业务 主要经营数据公告如下： 证券代码：603717 证券简称：天域生物 公告编号：2025-042 天域生物科技股份有限公司 二、特别提示 1、上述经营数据均未经审计，与定期报告披露的数据之间可能存在差异， 因此仅作为阶段性数据供投资者参考。 2、基于生猪市场价格大幅波动以及公司投苗节奏变化等因素影响，未来公 一、2025 年 5 月养殖行业主要经营数据 2025 年 5 月，公司销售生猪 2.48 万头，销售收入 4,038.75 万元，环比变动分 别为-29.18%、-31.93%，同比变动分别为 5.26%、-0.63%。 2025 年 1-5 月，公司累计销售生猪 17.24 万头，同比上升 16.21%；累计销售 收入 27,404.81 万元，同比上升 21.27%。 2025 年 5 月末，公司生猪存栏 14.14 万头，同比上升 0.46%，环 ...

Core Viewpoint - Multiple listed companies in the Shanghai and Shenzhen markets announced significant updates, providing insights for investors [2] Company Announcements - Wolong Real Estate will change its stock name to "Wolong New Energy" effective May 15, 2025, while the stock code remains unchanged [3] - Ningbo Fuda has terminated its major asset restructuring plans due to a lack of agreement on the final transaction scheme, with no significant impact on its current operations or financial status [4] - Land usage rights for a site in Shanghai will be returned by Shanghai Xiba due to external economic conditions, expected to reduce profits by approximately 36.42 million yuan, which is about 85% of the previous year's audited net profit [7] - Blue Dai Technology plans to acquire an 18% stake in Chongqing Taiguan for 34.11 million yuan, resulting in full ownership of the subsidiary [6] Performance Metrics - China Merchants Shekou reported a sales amount of 14.764 billion yuan in April, with a cumulative sales area of 2.0594 million square meters for the first four months of 2025 [8] - Shoukai Co. achieved a sales amount of 1.46 billion yuan in April, with a 24.92% decrease in sales area compared to the previous month [9] - Tiankang Biological reported a sales revenue of 380 million yuan from pig sales in April, with a 1.06% increase from the previous month [10] - Longyuan Co. reported a sales revenue of 125 million yuan from pig sales in April, with a 14.59% increase from the previous month [11] - New Wufeng sold 408,100 pigs in April, marking a 36.31% year-on-year increase [13] - Guangqi Group's April automobile sales were 116,400 units, a 12.66% year-on-year decline [16] - Jianghuai Automobile reported April sales of 30,764 units, down 3.55% year-on-year [17] - Shunong Development achieved a sales revenue of 1.533 billion yuan in April, a 0.68% year-on-year increase [19] Contracts and Agreements - Fuling Electric plans to sign a contract for an energy management project in Anhui Province, with an estimated investment of 488 million yuan and projected returns of 790 million yuan over eight years [21] - *ST Weihai has been pre-selected for a construction project with a bid of 108 million yuan, which represents 4.33% of its audited revenue for 2024 [22] Shareholder Actions - Liyuan Technology's shareholder plans to reduce holdings by up to 3.04 million shares, representing no more than 2.0008% of total shares [23] - Baoli Food's shareholder intends to reduce holdings by up to 3% of total shares, equating to approximately 12 million shares [24] Share Buybacks - Hongta Securities' chairman proposed a share buyback plan with a total amount between 100 million and 200 million yuan [26]

Group 1 - Yitong Century won a bid for a communication engineering construction service project from China Mobile, with a total bid amount of 228 million yuan (including tax) [1] - Zhiyuan New Energy plans to repurchase shares worth between 33 million and 66 million yuan, with a maximum repurchase price of 22.00 yuan per share [1] - GAC Group reported April automobile sales of 116,400 units, a year-on-year decrease of 12.66% [2] - JAC Motors reported April automobile sales of 30,764 units, a year-on-year decrease of 3.55% [3] Group 2 - Fosun Pharma's subsidiary received FDA approval for a clinical trial of a live biotherapeutic product aimed at treating androgenetic alopecia [4] - Liangxin Co. obtained multiple patent certificates, including 2 invention patents and 32 utility model patents [5] - Sainuo Medical's two products received medical device registration certificates in Mexico and Ecuador [5] - Huayu Pharmaceutical's two products received marketing approvals in France and Spain [6] Group 3 - Shengnong Development reported April sales revenue of 1.533 billion yuan, a year-on-year increase of 0.68% [6] - Hasi Lian's potassium chloride and sodium chloride injection passed the consistency evaluation [7] - Shapuaisi received approval for a supplemental application for levofloxacin eye drops [9] - Tianyu Biological reported April sales revenue of 59.32 million yuan from pig sales [10] Group 4 - *ST Weihai was pre-awarded a project worth 108 million yuan [12] - Luoniushan reported April sales revenue of 125 million yuan from pig sales, a year-on-year increase of 12.72% [13] - Minhe Co. reported April sales revenue of 68.30 million yuan from chick sales, a year-on-year increase of 0.51% [14] Group 5 - Double Ring Technology's application for a specific stock issuance was approved by the Shenzhen Stock Exchange [15] - Hualu Hengsheng plans to repurchase shares worth between 200 million and 300 million yuan [16] - Baolong Technology plans to repurchase shares worth between 100 million and 200 million yuan [17] Group 6 - Huasheng Technology's subsidiary plans to sell shares of a company for 200 million yuan [24] - *ST Gengxing's controlling shareholder plans to increase holdings worth between 30 million and 60 million yuan [25] - Ruihuatai's shareholder plans to reduce holdings by up to 1% of the company's shares [26] Group 7 - Foton Motor reported April commercial vehicle sales of 54,816 units, a year-on-year increase of 21.63% [20] - China Merchants Bank plans to invest 15 billion yuan to establish a financial asset investment company [22] - Jinchengxin plans to invest approximately 231 million USD in the Alacran copper-gold-silver mine project [23] Group 8 - Zhongji United's controlling shareholder plans to reduce holdings by up to 2% of the company's shares [30] - Ningbo Huaxiang signed a strategic cooperation agreement to strengthen collaboration in various areas [31] - SMIC reported a net profit of 1.356 billion yuan for Q1 2025, a year-on-year increase of 166.5% [32] Group 9 - FAW Fuwi received a project notification to develop seat products for a luxury brand, with a total sales amount expected to be 1.39 billion yuan [33] - Huakang Clean won a bid for a purification project worth 64.425 million yuan [34] - Lihua Co. reported April sales revenue of 1.125 billion yuan from chicken sales [35]

证券代码：603717 证券简称：天域生物 公告编号：2025-041 2025 年 4 月末，公司生猪存栏 13.32 万头，同比上升 3.38%，环比下降 4.80%。 天域生物科技股份有限公司 | 月份 | | 销售数量（万头） | | | 销售收入（万元） | 期末库存量 | | --- | --- | --- | --- | --- | --- | --- | | | | 当月 | 累计 | 当月 | 累计 | （万头） | | 年 2025 | 月 1 | 3.94 | 3.94 | 6,115.20 | 6,115.20 | 17.01 | | 2025 年 | 2 月 | 3.12 | 7.06 | 4,270.88 | 10,386.08 | 15.14 | | 年 2025 | 月 3 | 4.16 | 11.25 | 7,047.03 | 17,433.11 | 14.00 | | 2025 年 | 4 月 | 3.51 | 14.76 | 5,932.95 | 23,366.06 | 13.32 | 2025 年 4 月养殖业务主要经营数据公告 月度主要经营数据汇总如下： 本公司董事会 ...

Core Insights - Tianyu Biological (603717) reported sales of 35,100 pigs in April 2025, generating revenue of 59.32 million yuan, with a month-on-month decline of 16.38% in sales volume and 15.81% in revenue, but a year-on-year increase of 4.61% in sales volume and 25.66% in revenue [1] - From January to April 2025, the company sold a total of 147,600 pigs, representing a year-on-year increase of 18.28%, with total revenue reaching 234 million yuan, up 26.07% year-on-year [1] - As of the end of April 2025, the company's pig inventory stood at 133,200 heads, reflecting a year-on-year increase of 3.38% but a month-on-month decrease of 4.80% [1]

锦 天 城 律师事务 所 ALLBRIGHT LAW OFFICES 地址:上海市浦东新区银城中路 501 号上海中心 11、12 层 电话:021-20511000 传真:021-20511999 邮编:200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于天域生物科技股份有限公司 上海市锦天城律师事务所 关于天域生物科技股份有限公司 2024 年年度股东大会的 2024 年年度股东大会的法律意见书 法律意见书 致:天域生物科技股份有限公司 上海市锦天城律师事务所(以下简称"本所")接受天域生物科技股份有限 公司(以下简称"公司")委托,就公司召开 2024年年度股东大会(以下简称 "本次股东大会")的有关事宜,根据《中华人民共和国公司法》(以下简称"《公 司法》")《上市公司股东会规则》等法律、法规和其他规范性文件以及《天域 生物科技股份有限公司章程》(以下简称"《公司章程》")的有关规定,出具 本法律意见书。 为出具本法律意见书,本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则(试行)》等规定,严格履行 了法定职责,遵循了勤勉尽责和诚实 ...